All Stories

  1. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

    Article • Vascular Health and Risk Management, November 2013, Taylor & Francis

    Dr Joanne Tomassini